^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Waldenstrom Macroglobulinemia
    Drug:Venclexta (venetoclax) (Bcl2 inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Published date:
    12/07/2021
    Excerpt:
    Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma...Other recommended regimens...Venetoclax